VITAFOAM NIGERIA PLC
UNAUDITED CONSOLIDATED AND SEPARATE INTERIM FINANCIAL
STATEMENTS
FOR THE YEAR ENDED SEPTEMBER 30, 2023
VITAFOAM NIGERIA PLC
QUARTER 4 ENDED 30 SEPT 2023
SECURITIES TRADING POLICY
In compliance with Rule 17.15 Disclosure of Dealings in Issuers' Shares, Rulebook of The Exchange 2015 (Issuers' Rule), Vitafoam Nigeria Plc maintains a Security Trading Policy (Policy) which guides Directors, Audit Committee members, employees and all individuals categorized as insiders in relation to their dealings in the Company's shares. The Policy undergoes periodic review by the Board and is updated accordingly. The Company has made specific inquiries of all its directors and other insiders and is not aware of any infringement of the Policy during the period.
Vitafoam Nigeria Plc
Unaudited Consolidated and separate interim financial statements for the year ended September 30, 2023
Content
Index | Page | |
Statements of profit or loss and other comprehensive income | 2 | |
Statement of Financial Position | 3 | |
Consolidated and Separate statement of changes in equity | 4 | - 5 |
Statement of Cash Flows | 6 | - 7 |
Significant Accounting Policies | 8 - 19 | |
Notes to the Unaudited Consolidated And Separate Interim Financial Statements | 20 | - 26 |
1
Vitafoam Nigeria Plc
Unaudited Consolidated and Separate Interim Financial Statements for the year ended September 30, 2023
Statements of profit or loss and other comprehensive income
Group | Company | |||||||||
12 Months to | 12 Months to | 3 Months to | 3 Months to | 12 months to | 12 months to | 3 Months to | 3 Months to | |||
Notes | 30-Sept-23 | 30-Sept-22 | 30-Sept-23 | 30-Sept-22 | 30-Sept-23 | 30-Sept-22 | 30-Sept-23 | 30-Sept-22 | ||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |||
Revenue | 3 | 52,832,220 | 46,310,015 | 14,276,985 | 11,662,891 | 47,724,365 | 42,128,595 | 11,794,981 | 9,858,395 | |
Cost of Sales | 4 | (34,265,164) | (30,912,952) | (9,565,465) | (8,042,973) | (32,602,875) | (29,270,339) | (8,138,872) | (7,006,204) | |
Gross profit | 18,567,056 | 15,397,063 | 4,711,520 | 3,619,918 | 15,121,490 | 12,858,256 | 3,656,109 | 2,852,191 | ||
Other gains and losses | 8 | 370,681 | 397,915 | 162,976 | 55,055 | 509,633 | 551,552 | 103,036 | 80,583 | |
Administrative expenses | 5 | (9,780,010) | (6,798,469) | (2,680,432) | (2,224,348) | (7,747,962) | (5,016,862) | (1,981,482) | (1,596,960) | |
Distribution expenses | 6 | (2,097,532) | (2,075,781) | (472,538) | (464,303) | (1,948,921) | (1,986,774) | (419,294) | (441,704) | |
Operating profit | 7,060,195 | 6,920,728 | 1,721,526 | 986,322 | 5,934,240 | 6,406,172 | 1,358,369 | 894,110 | ||
Finance income | 1,308,725 | 998,618 | 391,516 | 322,302 | 1,307,939 | 988,644 | 391,441 | 321,075 | ||
Finance cost | 7 | (2,193,676) | (704,986) | (1,309,928) | (282,611) | (2,173,918) | (646,570) | (1,309,233) | (274,728) | |
Profit before taxation | 6,175,244 | 7,214,360 | 803,114 | 1,026,013 | 5,068,261 | 6,748,246 | 440,577 | 940,457 | ||
Taxation | (1,820,506) | (2,692,082) | (142,345) | (406,517) | (1,414,229) | (2,337,135) | (17,354) | (313,950) | ||
Profit for the period | 4,354,738 | 4,522,278 | 660,769 | 619,496 | 3,654,032 | 4,411,111 | 423,223 | 626,507 | ||
Exchange difference on translating foreign operations | (216,421) | 83,476 | (81,573) | 20,134 | - | - | - | - | ||
Remeasurements on net defined benefit liability | - | 49,845 | - | - | - | 49,845 | - | - | ||
Gain on valuation of investment in equity instruments designated as at FVTOCI | 6,568 | 6,915 | - | 7,423 | 6,568 | 6,915 | - | 7,423 | ||
Other comprehensive income | (209,853) | 140,236 | (81,573) | 27,557 | 6,568 | 56,760 | - | 7,423 | ||
Total comprehensive income for the period | 4,144,885 | 4,662,514 | 579,196 | 647,053 | 3,660,600 | 4,467,871 | 423,223 | 633,930 | ||
Profit attributable to : | ||||||||||
Equity holders of the parent | 3,886,044 | 4,223,481 | 550,631 | 540,153 | 3,660,600 | 4,411,111 | 423,223 | 626,507 | ||
Non-controlling interests | 468,694 | 298,797 | 110,138 | 79,343 | - | - | - | - | ||
4,354,738 | 4,522,278 | 660,769 | 619,496 | 3,660,600 | 4,411,111 | 423,223 | 626,507 | |||
Earnings per share for profit from total operations attributable to equity holders | ||||||||||
of parent | ||||||||||
Basic and diluted | 310.67 k | 338.00 k | 44.02 k | 43.18 k | 292.65 k | 353.00 k | 33.83 k | 50.09 k |
2
Vitafoam Nigeria Plc
Unaudited Consolidated and separate interim financial statements for the year ended September 30, 2023
Statement of Financial Position as at
Group | Company | ||||
30th | 30th | 30th | 30th | ||
September | September | ||||
September | 2022 | September | 2022 | ||
2023 | 2023 | ||||
Note(s) | N'000 | N'000 | N'000 | N'000 | |
Assets | |||||
Non-Current Assets | |||||
Property, plant and equipment | 9 | 7,007,217 | 6,274,919 | 3,197,789 | 3,004,961 |
Intangible assets | 58,639 | 21,364 | 54,822 | 17,833 | |
Investment property | - | - | 1,707,963 | 1,778,044 | |
Investments in subsidiaries | - | - | 1,699,248 | 1,032,139 | |
Investment in financial assets | 12,301 | 5,732 | 12,301 | 5,732 | |
Finance lease receivables | 55,211 | 95,469 | 55,211 | 95,469 | |
Right of use assets | 185,631 | 193,039 | 185,631 | 193,039 | |
7,318,999 | 6,590,523 | 6,912,965 | 6,127,217 | ||
Current Assets | |||||
Inventories | 11 | 15,354,454 | 13,864,400 | 11,892,511 | 11,003,143 |
Other assets | 19 | 2,851,309 | 2,110,018 | 2,636,677 | 2,022,747 |
Trade and other receivables | 12 | 1,839,473 | 1,593,401 | 3,340,164 | 2,774,988 |
Cash and bank balances | 15 | 21,753,103 | 15,278,674 | 21,092,837 | 14,985,016 |
41,798,339 | 32,846,493 | 38,962,189 | 30,785,894 | ||
Total Assets | |||||
49,117,338 | 39,437,016 | 45,875,154 | 36,913,111 | ||
Equity and Liabilities | |||||
Equity | |||||
Share capital | 16 | 625,422 | 625,422 | 625,422 | 625,422 |
Reserves | 76,366 | 286,218 | 457,460 | 450,892 | |
Accumulated profit | 15,743,454 | 13,750,771 | 15,697,430 | 13,936,759 | |
16,445,242 | 14,662,411 | 16,780,312 | 15,013,073 | ||
Non-controlling interest | 1,195,744 | 1,006,107 | - | - | |
17,640,986 | 15,668,518 | 16,780,312 | 15,013,073 | ||
Liabilities | |||||
Non-Current Liabilities | |||||
Borrowings | 17 | 55,402 | 166,729 | - | - |
Retirement benefit obligation | 933,750 | 761,874 | 803,971 | 761,874 | |
Lease liabilities | 181,716 | 160,099 | 181,716 | 160,099 | |
Deferred tax | 709,586 | 708,524 | 764,945 | 764,945 | |
1,880,454 | 1,797,226 | 1,750,632 | 1,686,918 | ||
Current Liabilities | |||||
Current tax payable | 18 | 1,919,850 | 2,759,597 | 1,412,970 | 2,337,389 |
Trade and other payables | 14 | 6,183,403 | 5,229,046 | 4,438,595 | 3,894,901 |
Borrowings | 17 | 21,492,645 | 13,981,582 | 21,492,645 | 13,980,830 |
Deferred income | - | 1,047 | - | - | |
29,595,898 | 21,971,272 | 27,344,210 | 20,213,120 | ||
Total Liabilities | |||||
31,476,352 | 23,768,498 | 29,094,842 | 21,900,038 | ||
Total Equity and Liabilities | |||||
49,117,338 | 39,437,016 | 45,875,154 | 36,913,111 |
The unaudited consolidated and separate interim financial statements and the notes on pages 2 to 26, were approved by the board on 27 October, 2023 and were signed on its behalf by:
Group Managing Director/CEO
Taiwo Adeniyi
FRC/2015/IOND/00000010639
Finance Director
Joseph Alegbesogie, FCA
FRC/2013/ICAN/00000003728
The accounting policies on pages 8 to 19 and the notes on pages 20 to 26 form an integral part of the unaudited consolidated and separate interim financial statements.
3
Vitafoam Nigeria Plc
Unaudited Consolidated and Separate Interim Financial Statements for the year ended September 30, 2023
Consolidated and Separate statement of changes in equity
Share capital | Foreign | Other reserve | Fair value | Retained | Total | Non-controlling | Total equity | |||||||||||||
currency | adjustment | earnings | attributable to | interest | ||||||||||||||||
translation | assets- | equity holders | ||||||||||||||||||
reserve | available-for- | of the group / | ||||||||||||||||||
sale reserve | company | |||||||||||||||||||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |||||||||||||
Group | ||||||||||||||||||||
Balance at 01 October 2021 | 625,422 | (153,750) | 393,018 | (43,441) | 11,333,365 | 12,154,614 | 781,067 | 12,935,681 | ||||||||||||
Profit for 12 months | 3,338,647 | 3,338,647 | 274,618 | 3,613,26 | ||||||||||||||||
Other comprehensive income | - | 56,032 | - | 1,610 | - | 57,642 | - | 57,642 | ||||||||||||
Total comprehensive income for the period | - | 56,032 | - | 1,610 | 3,338,647 | 3,396,289 | 274,618 | 3,670,907 | ||||||||||||
Dividends paid | - | - | - | - | (1,876,268) | (1,876,268) | (211,393) | (2,087,661) | ||||||||||||
Balance at 30 September 2022 | 625,422 | (97,718) | 393,018 | (41,831) | 12,795,744 | 13,674,635 | 844,291 | 14,518,926 | ||||||||||||
Balance at 01 October 2022 | 625,422 | (97,718) | 393,018 | (41,831) | 13,730,423 | 14,609,314 | 868,471 | 15,477,785 | ||||||||||||
- | - | - | - | - | - | - | - | |||||||||||||
Changes in NCI as a result of share allotment not resulting in loss of control | - | - | - | - | - | - | 137,636 | 137,636 | ||||||||||||
Stattute barred unclaimed dividend income | - | - | - | - | 20,348 | 20,348 | - | 20,348 | ||||||||||||
Balance at 30 September, 2022 | 625,422 | (70,274) | 393,018 | (36,526) | 13,750,771 | 14,662,411 | 1,006,107 | 15,668,518 | ||||||||||||
Profit for 12 months | ||||||||||||||||||||
- | - | - | - | 3,886,044 | 3,886,044 | 468,694 | 4,354,738 | |||||||||||||
Other comprehensive income | - | (216,421) | - | 6,568 | - | (209,853) | - | (209,853) | ||||||||||||
Total comprehensive income for the period | ||||||||||||||||||||
- | (216,421) | - | 6,568 | 3,886,044 | 3,676,191 | 468,694 | 4,144,885 | |||||||||||||
Statute barred unclaimed dividend income | ||||||||||||||||||||
- | - | - | - | 7,923 | 7,923 | - | 7,923 | |||||||||||||
Dividends | - | - | - | - | (1,901,284) | (1,901,284) | (279,057) | (2,180,341) | ||||||||||||
Balance at 30 September 2023 | ||||||||||||||||||||
625,422 | (286,695) | 393,018 | (29,958) | 15,743,454 | 16,445,241 | 1,195,744 | 17,640,985 | |||||||||||||
Note(s) | 16 |
4
Vitafoam Nigeria Plc | ||||||||||||||||||||
Unaudited Consolidated and separate interim financial statements for the year ended September 30, 2023 | ||||||||||||||||||||
Consolidated and Separate statement of changes in equity | ||||||||||||||||||||
Share capital | Foreign currency | Fair value adjustment | Retained income | Total equity | ||||||||||||||||
translation reserve | assets-available-for- | |||||||||||||||||||
sale reserve | ||||||||||||||||||||
N'000 | N'000 | N'000 | N'000 | N'000 | ||||||||||||||||
Company | ||||||||||||||||||||
Balance at 01 October 2021 | 625,422 | 487,418 | (43,441) | 11,331,723 | 12,401,122 | |||||||||||||||
Profit for the 12 months | 3,384,366 | 3,384,366 | ||||||||||||||||||
Other comprehensive income | 1,610 | 1,610 | ||||||||||||||||||
Dividens paid | - | - | - | (1,876,268) | (1,876,268) | |||||||||||||||
Balance at 30 September 2022 | 625,422 | 487,418 | (41,831) | 12,839,821 | 13,910,830 | |||||||||||||||
Balance at 01 October 2021 | 625,422 | 487,418 | (43,441) | 11,331,723 | 12,401,122 | |||||||||||||||
Profit for the year | - | - | 4,411,111 | 4,411,111 | ||||||||||||||||
Other comprehensive income | - | - | 6,915 | 49,845 | 56,760 | |||||||||||||||
Total comprehensive income for the year | - | - | 6,915 | 4,460,956 | 4,467,871 | |||||||||||||||
Statute barred unclaimed received | - | - | - | 20,348 | 20,348 | |||||||||||||||
Dividends | - | - | - | (1,876,268) | (1,876,268) | |||||||||||||||
Balance at 30 September, 2022 | 625,422 | 487,418 | (36,526) | 13,936,759 | 15,013,073 | |||||||||||||||
Profit for the 12 months | - | - | - | 3,654,032 | 3,654,032 | |||||||||||||||
Other comprehensive income | - | - | 6,568 | - | 6,568 | |||||||||||||||
Total comprehensive income for the period | - | - | 6,568 | 3,654,032 | 3,660,600 | |||||||||||||||
Statute barred unclaimed divided income | - | - | - | 7,923 | 7,923 | |||||||||||||||
Dividends | - | - | - | (1,901,284) | (1,901,284) | |||||||||||||||
Balance at 30 September 2023 | 625,422 | 487,418 | (29,958) | 15,697,430 | 16,780,312 | |||||||||||||||
Note(s) | 16 |
The accounting policies on pages 8 to 19 and the notes on pages 20 to 26 form an integral part of the unaudited consolidated and separate interim financial statements.
5
Vitafoam Nigeria Plc
Unaudited Consolidated and separate interim financial statements for the year ended September 30, 2023
Statement of Cash Flows
Group | Company | ||||||||
September 30, | September 30, September 30, | Septmber 30, | |||||||
2023 | 2022 | 2023 | 2022 | ||||||
Note(s) | N'000 | N'000 | N'000 | N'000 | |||||
Cash flows from operating activities | |||||||||
Profit before taxation | 6,175,244 | 7,214,360 | 5,068,261 | 6,748,246 | |||||
Adjustments for: | |||||||||
Depreciation and amortisation | 900,954 | 789,563 | 528,467 | 439,007 | |||||
Profit on sale of assets | (44,338) | (4,760) | (43,990) | 537 | |||||
Adjustment on property,plant and equipment | 23,582 | - | 23,582 | - | |||||
Translation adjustment on PPE | (177,220) | 168,326 | - | - | |||||
Finance income | (1,308,725) | (998,618) | (1,307,939) | (988,644) | |||||
Finance cost | 877,683 | 704,986 | 2,173,918 | 646,570 | |||||
Fair value loss on investment in financial | - | 8,481 | - | 8,481 | |||||
assests | |||||||||
Effects of exchange rate movement on cash | 36,663 | 64,669 | 36,663 | 64,669 | |||||
balance | |||||||||
Effect of corrected exchange difference | - | - | - | 12,851 | |||||
Actuarial loss on long service award | - | 5,510 | - | 5,510 | |||||
Movement in investment in subsidiary | - | - | - | (40,000) | |||||
Service cost | 259,748 | 137,521 | 129,969 | 137,521 | |||||
Gain/Loss on exchange difference translation | (216,421) | 83,476 | - | - | |||||
Changes in working capital: | |||||||||
Inventories | (1,490,054) (5,239,639) | (889,368) (4,494,140) | |||||||
Trade and other receivables | (124,435) | (806,556) | (443,539) | (402,995) | |||||
Other assets | (741,291) | 2,767,162 | (613,930) | 2,745,257 | |||||
Trade and other payables | 807,642 | 2,456,494 | 344,886 | 1,894,136 | |||||
Deferred income | (1,047) | (224,705) | - | (220,473) | |||||
Deferred tax liabilities | 1,062 | - | - | - | |||||
Benefit paid | (87,873) | (94,359) | (87,873) | (94,359) | |||||
4,891,174 | 7,031,911 | 4,919,107 | 6,462,174 | ||||||
Tax paid | (2,660,253) | (2,484,970) | (2,338,648) | (2,121,028) | |||||
Net cash from operating activities | 2,230,921 | 4,546,941 | 2,580,459 | 4,341,146 | |||||
Cash flows from investing activities | |||||||||
Purchase of property, plant and equipment | 9 | (1,489,184) | (723,234) | (683,619) | (508,408) | ||||
Proceeds from sale of property, plant and equipment | 9 | 68,499 | 26,098 | 68,388 | 14,212 | ||||
Acquisition of shares in subsidiary | - | - | - | (103,567) | |||||
Purchase of intangible assets | (44,457) | (5,244) | (43,597) | (4,564) | |||||
Purchase of investment property | - | - | (1,559) | - | |||||
- | - | - | - | ||||||
Finance receipt | 40,258 | 26,717 | 40,258 | 26,717 | |||||
Finance lease receivable | - | (65,836) | - | (65,836) | |||||
Interest received | 1,187,088 | 906,899 | - | 896,925 | |||||
Net cash from investing activities | (237,796) | 165,400 | (620,129) | 255,479 | |||||
Cash flows from financing activities | |||||||||
Share premium adjustment | 16 | - | - | - | - | ||||
Proceeds from borrowings | 14,590,116 | 14,212,868 | 14,590,116 | 14,212,868 | |||||
Repayment of borrowings | (7,190,380) | (11,860,031) | (7,078,301) | (11,618,249) | |||||
Statue barred Unclaimed dividend received | 7,923 | 20,348 | 7,923 | 20,348 | |||||
Dividends paid | (2,180,341) | (2,087,661) | (1,901,284) | (1,876,268) | |||||
Interest income | - | - | 1,186,302 | - | |||||
Interest paid | (709,351) | (489,162) | (1,953,493) | (430,746) | |||||
Proceeds on sale of shares in subsidiary to non-controlling interest where control is not | - | 137,636 | - | - | |||||
lost |
6
Vitafoam Nigeria Plc
Unaudited Consolidated and separate interim financial statements for the year ended September 30, 2023
Statement of Cash Flows
Group | Company | |||||||
30-Sept-23 | 30-Sept-22 | 30-Sept-23 | 30-Sept-22 | |||||
Note(s) | N'000 | N'000 | N'000 | N'000 | ||||
Net cash from financing activities | 4,517,967 | (66,002) | 4,184,154 | 307,953 | ||||
Net cash and cash equivalent for the period | 6,511,092 | 4,646,339 | 6,144,484 | 4,904,578 | ||||
Cash at the beginning of the period | 15,278,674 | 10,697,004 | 14,985,016 | 10,145,107 | ||||
Effect of exchange rate movement on cash balances | (36,663) | (64,669) | (36,663) | (64,669) | ||||
15 | ||||||||
Cash and cash equivalent at the end of the period | 21,753,103 | 15,278,674 | 21,092,837 | 14,985,016 | ||||
The accounting policies on pages 8 to 19 and the notes on pages 20 to 26 form an integral part of the unaudited consolidated and separate interim financial statements.
7
Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Vitafoam Nig Ltd. published this content on 27 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 October 2023 17:12:26 UTC.